E
Ayurcann Holdings Corp. AYUR
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 10/31/2024Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to E+ from D- on 10/31/2024 due to a decline in the total return index and volatility index.
D
Sell 8/30/2024Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D- from E+ on 8/30/2024 due to a noticeable increase in the total return index, valuation index and volatility index.
E
Sell 7/5/2024Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to E+ from D- on 7/5/2024 due to a decline in the valuation index.
D
Sell 6/10/2024Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D- from E+ on 6/10/2024 due to a significant increase in the growth index, valuation index and total return index. Earnings per share increased from -$0.0035 to -$0.0013, EBIT increased 48.64% from -$440.6 to -$226.3, and total revenue increased 12.76% from $4.27M to $4.81M.
E
Sell 6/7/2024Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to E+ from D- on 6/7/2024 due to a decline in the volatility index.
D
Sell 5/23/2024Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D- from E+ on 5/23/2024 due to a noticeable increase in the volatility index and total return index.
E
Sell 10/25/2023Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to E+ from D- on 10/25/2023 due to a decline in the total return index and volatility index.
D
Sell 10/10/2023Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D- from E+ on 10/10/2023 due to an increase in the total return index and volatility index.
E
Sell 9/25/2023Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to E+ from D- on 9/25/2023 due to a decline in the solvency index and volatility index. Debt to equity increased from 0.06 to 0.1, and the quick ratio declined from 0.89 to 0.77.
D
Sell 10/28/2022Downgrade
Ayurcann Holdings Corp. (AYUR) was downgraded to D- from D on 10/28/2022 due to a significant decline in the efficiency index, solvency index and total return index. Net income declined 343.03% from -$433.2 to -$1.92M, debt to equity increased from 0.03 to 0.04, and total capital declined 23.47% from $5.32M to $4.07M.
D
Sell 5/1/2022Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D from D- on 5/1/2022 due to an increase in the growth index, valuation index and solvency index. EBIT increased 339.55% from $102.4 to $450.1, total revenue increased 72.54% from $1.48M to $2.56M, and debt to equity declined from 0.04 to 0.03.
D
Sell 1/3/2022Upgraded
Ayurcann Holdings Corp. (AYUR) was upgraded to D- from E on 1/3/2022 due to a noticeable increase in the efficiency index, solvency index and valuation index. Total capital increased 0.14% from $4.22M to $4.22M.
E
Sell 11/3/2021None
Ayurcann Holdings Corp. (AYUR) was downgraded to E from U on 11/03/2021.
Weiss Ratings